Seyedkazemi Setareh
- SEC CIK
- 0001903088
No open-market purchases or sales filed in the past year.
Current role at each company
- ADVM Adverum Biotechnologies, Inc.CHIEF DEVELOPMENT OFFICERas of Dec 10, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Seyedkazemi Setareh as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 16, 2025 (view filing) | May 15 | 1 day | Seyedkazemi SetarehCHIEF DEVELOPMENT OFFICER | SSale | −924 | $2.00 | −$1.85K | −6.3%13.8K after | |
| Sep 18, 2023 (view filing) | Sep 15 | 3 days | Seyedkazemi SetarehChief Development Officer | SSale | −6.20K | $1.52 | −$9.43K | −11.5%47.7K after | 2 lots |
| Sep 21, 2022 (view filing) | Sep 19 | 2 days | Seyedkazemi SetarehChief Development Officer | SSale | −6.06K | $1.07 | −$6.48K | −11.2%47.9K after | |
| May 24, 2022 (view filing) | May 23 | 1 day | Seyedkazemi SetarehChief Development Officer | PPurchase | +20.0K | $0.84 | +$16.8K | +3,333.3%20.6K after |